报告题目：Bacterial Ghost Platform Technology: Applications in Drug Delivery and White Biotechnology
报 告 人：Prof. Werner Lubitz
工作单位：University of Vienna
Prof. Dr. Werner Lubitz holds an MSc and a PhD in Microbiology and Genetics from the Technical University of Munich, Germany. He obtained his postdoctoral training at the Universities of Lausanne and Basel, Switzerland; Uppsala, Sweden; Victoria, Canada and at the Max Planck Institute for Psychiatry, Munich, Germany. Dr. Lubitz was an Associate Professor of Microbiology at the University of Kaiserslautern, Germany and Associate Professor of Genetics at the University of Munich, Germany. Since 1987, he has been a Full Professor at the University of Vienna, Austria, first at the Institute of Microbiology and Genetics, and recently at the Department of Medicinal Chemistry. Werner Lubitz has published more than 100 papers in internationally peer-reviewed journals. As inventor of the Bacterial Ghost Platform Technology he holds an extensive international patent portfolio. In 1998, Dr. Lubitz founded the biotech company BIRD-C in Vienna.